Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
160,907,362
-
Share change
-
-3,806,305
-
Total reported value
-
$27,326,078,670
-
Put/Call ratio
-
72%
-
Price per share
-
$169.92
-
Number of holders
-
484
-
Value change
-
-$558,523,455
-
Number of buys
-
305
-
Number of sells
-
153
Institutional Holders of SEATTLE GENETICS INC - COM (SGEN) as of Q2 2020
As of 30 Jun 2020,
SEATTLE GENETICS INC - COM (SGEN) was held by
484 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
160,907,362 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, Capital International Investors, BlackRock Inc., VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, PRIMECAP MANAGEMENT CO/CA/, WELLINGTON MANAGEMENT GROUP LLP, BAILLIE GIFFORD & CO, JPMORGAN CHASE & CO, and FMR LLC.
This page lists
484
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.